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Abstract
Exhaled nitric oxide (eNO) is decreased by cigarette smoking. The hypothesis that oxides of
nitrogen (NOX) in cigarette smoke solution (CSS) may exert a negative feedback mechanism upon
NO release from epithelial (AEC, A549, and NHTBE) and basophilic cells (RBL-2H3) was tested in
vitro. CSS inhibited both NO production and degranulation (measured as release of beta-
hexosaminidase) in a dose-dependent manner from RBL-2H3 cells. Inhibition of NO production by
CSS in AEC, A549, and NHTBE cells was also dose-dependent. In addition, CSS decreased
expression of NOS mRNA and protein expression. The addition of NO inhibitors and scavengers
did not, however, reverse the effects of CSS, nor did a NO donor (SNP) or nicotine mimic CSS.
N-acetyl-cysteine, partially reversed the inhibition of beta-hexosaminidase release suggesting CSS
may act via oxidative free radicals. Thus, some of the inhibitory effects of CSS appear to be via
oxidative free radicals rather than a NOX -related negative feedback.
Introduction
Cigarette smoke is a complex medium containing approx-
imately 4000 different constituents [1] separated into gas-
eous and particulate phases. The components of the
gaseous phase include carbon monoxide, carbon dioxide,
ammonia, hydrogen dioxide, hydrogen cyanide, volatile
sulphur-containing compounds, nitrogen oxides (includ-
ing nitric oxide, NO), and other nitrogen-containing com-
pounds. The particulate phase contains nicotine, water
and tar [2]. Pulmonary effects of cigarette smoke include
chronic obstructive pulmonary disease, increased airway
reactivity, exacerbations of asthma, and an increased fre-
quency of pulmonary infections. These effects are consid-
ered to be due to the direct actions of cigarette-derived
toxins and ciliotoxins causing connective tissue destruc-
tion, hypersecretion, pooling of mucus and blebbing of
membranes of endothelial cells. Cigarette smoke also
reduces levels of exhaled nitric oxide in active and passive
smokers, suggesting that it inhibits NO production [3-5].
Su et al [6] have shown that exposure to cigarette smoke
extract inhibits the activity, protein and messenger RNA of
NO synthase (eNOS) in pulmonary artery endothelial
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cells irreversibly. Whether alterations in NO play a role in
the increased risk of pulmonary disease is not completely
understood.
Mast cells play a crucial role in acute and allergic inflam-
mation, and have high-affinity receptors for IgE (FcεRI)
on their surface. Cross-linking of surface IgE molecules
results in exocytosis of preformed mediators such as
amines and proteases, as well as release of newly gener-
ated mediators including leukotrienes, prostaglandins
and a variety of cytokines [7]. In the lungs and skin of
smokers mast cells increase in absolute numbers and
smoking may be associated with activation of mast cells
[8,9]. They may contribute to some of the changes seen in
smoking by releasing chemotactic factors, secreting pro-
teases and other mediators. Some reports suggest that NO
may be a participant in mast cell activation, but others
suggest that it may also inhibit mast cell pre-formed medi-
ator release [10,11]. Since cigarette smoke contains high
levels of NO, it was hypothesised that NO may exert an
inhibitory effect on degranulation, perhaps via negative
feedback.
Airway epithelial cells (AEC) are important regulators of
inflammation in the airway [12]. They have a function in
host defence and play a significant role in airway inflam-
mation by releasing NO, a potentially important mediator
of airway inflammation [13,14], as well as releasing other
mediators and recruiting inflammatory cells [12,15,16].
Cigarette smoke interferes with and inhibits the normal
function of AEC by a variety of mechanisms. Some of
these include decreases in the level of exhaled NO,
enhanced release of pro-inflammatory cytokines, and
inhibition of the airway repair process [5,17,18].
This study was designed to examine whether cigarette
smoke induces dysfunction of airway mast cells and epi-
thelial cells via the donation of cigarette-derived NO. It
was hypothesized that the NO from cigarette smoke may
induce negative feedback and cause a reduction in endog-
enous NO production from mast cells and epithelial cells.
Thus, NO scavengers were added to a cigarette smoke
solution (CSS). In addition, a NO donor was studied as a
positive control and NO inhibitors as controls for endog-
enous NO production. NO generation was measured as
nitrite.
A rat basophilic leukemia cell line, RBL-2H3 representing
mucosal type mast cells [19], which has been extensively
applied in studies of mast cell biochemistry and signal-
ling, was used as an in vitro model of mast cells for this
study. Beta-hexosaminidase was used as a marker of mast
cell activation and degranulation. Primary cultures of
murine epithelial cells, normal human tracheobronchial
(NHTBE) and transformed alveolar epithelial (A549) cell
lines were studied in parallel [20,21].
Materials and methods
Cell culture and polymerase chain reaction (PCR) rea-
gents were purchased from Invitrogen Corporation (Syd-
ney, Australia) and chemical reagents were bought from
Sigma-Aldrich, (Sydney, Australia) unless otherwise spec-
ified. Animal tissue research was approved by the institu-
tional animal ethics committee.
Cell Culture
The rat basophilic leukemia cell line, RBL-2H3 (ATCC,
American Type Culture Collection, Rockville, MD, USA)
was grown in complete Eagle Minimal Essential Medium
with 15% fetal bovine serum (FBS), 0.1 mM non-essential
amino acids, 1.0 mM sodium pyruvate, 2.0 mM L-
glutamine, 50 IU/ml penicillin and 50 µg/ml streptomy-
cin. A549 cell line (ATCC) was maintained in complete F-
12 Nutrient Medium supplemented with 10% FBS, 50 IU/
ml penicillin and 50 µg/ml streptomycin. Mouse airway
tracheal epithelial cells (AEC), obtained from tracheas of
8–10 week-old specific pathogen-free BALB/C, were cul-
tured and maintained as previously described [20] on col-
lagen-coated plastic ware. Third- to fifth-passage AEC were
used for experiments. Normal human tracheal bronchial
epithelial cells (NHTBE, Clonetics, USA) were maintained
in Bronchial Epithelial Cell Growth Medium (BEGM) Bul-
let Kit (CC-3170, Clonetics, San Diego, CA, USA).
Preparation of the cigarette smoke solution (CSS)
Water-soluble extract of cigarette smoke (both gas and
particulate phases) was prepared as described previously
[22]. Briefly, mainstream smoke from commercial ciga-
rettes (Marlboro, Philip Morris, Australia) was drawn
through 1 ml of medium by the application of a vacuum
to the vessel containing the medium. Each cigarette was
burned for 5 min, and 5 cigarettes were used for each mil-
lilitre of the appropriate medium for different cells. The
pH of the resultant extract was titrated to pH 7.4, and
diluted with medium. Solutions ranging from 0.125% to
1.0% were used in the present study in response to prelim-
inary experiments which indicated that these were non-
toxic concentrations. CSS was used within 2 hrs of prepa-
ration, and the NOx content of the CSS was in the range
1.3–2.6 mM, mean 1.76 (S.E. 0.67) mM. CSS was incu-
bated also in control wells with media but without cells at
the same concentrations and for the time periods. The
final NOx content in these latter wells was subtracted
from the values in the experimental wells.
Beta-hexosaminidase secretion assay
106/ml RBL-2H3 cells were sensitised with 100 ng/ml of
mouse monoclonal IgE anti-DNP overnight. Cells were
washed twice with phosphate buffered saline (PBS) andRespiratory Research 2005, 6:108 http://respiratory-research.com/content/6/1/108
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pre-incubated with different concentrations of CSS for a
further 6 h prior to activation with either 100 ng/ml DNP-
HSA antigen or 10 µmol/L of calcium ionophore A23187.
Beta-hexosaminidase release from RBL-2H3 was meas-
ured by incubating 25 µl of the supernatant or lysed cell
pellet with 5% Triton-100 with 25 µl of p-NAG in a 96-
well plate (Nunc, Roskilde, DM) for 2 h at 37°C. The reac-
tion was stopped with 250 µl 0.2 M glycine (pH 10.6) and
the resultant change in absorbance read at 405 nm. The
net percentage of release of beta-hexosaminidase was cal-
culated by the following formula:
net percent release (%) = [S/(S+P)-Scontrol/(Scontrol+Pcon-
trol)] × 100,
where S, P are the mediator contents of supernatants and
pellets of stimulated cells, respectively, Scontrol/(Scon-
trol+Pcontrol)(%) is spontaneous release of mediator with-
out a stimulus.
Nitrite and nitrate measurements
RBL-2H3, A549, NHTBE and AEC were cultured in com-
plete media until 90% confluent. Cells were washed with
PBS and incubated with nicotine (31.25 ng/ml–400 ng/
ml) or CSS as above for a further 24 h or 48 h (A549 cells),
then measured as nitrite and nitrate (NOx) accumulation
in media as described previously [23-25]. Briefly, nitrate
was measured as nitrite after enzymatic conversion by
nitrate reductase. Volumes of 20 µl NADPH, 10 µl FAD
and 20 µl nitrate reductase were diluted in reaction buffer
and added to yield final concentrations of 50 µmol/L, 5
µmol/L and 200 IU/L, respectively. Samples of 50 µl each
were subsequently incubated for 1 hour at 37°C. Next, 10
µl of 2,3-diaminonaphthalene (DAN, 0.05 mg/ml in 0.62
M HCl) was added to each well and incubated for an addi-
tional 10 mins. The reaction was stopped by 10 µl of 2.8
M NaOH. The fluorescence of final product (1H-naphtho-
triazole) was measured using Perkin-Elmer Cytofluor
4000 plate reader (excitation 360/40, emission 395/25,
gain 50). Nitrite concentration was calculated using a
standard curve of serially diluted sodium nitrite.
RT-PCR analysis of iNOS and eNOS expression
Cells were incubated with 1%CSS at different time-points
(3 h, 6 h, 24 h). Total cellular RNA was extracted using
TRI-Reagent (Sigma) according to the manufacturer's
instructions. First-strand cDNA was synthesized from 1 µg
total RNA with SuperScript II using Oligo (dT) as primers
(Invitrogen, Carlsbad, CA, USA). PCR was performed on
the reverse transcription products using specific oligonu-
cleotide primers, and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was used as a housekeeping gene.
PCR reactions contained 2 µL cDNA, 10 µM primers
(Table 1), 1.5 mmol/L Mg, 200 µmol/L dNTPs and 0.5 IU
Platinum Taq polymerase (Invitrogen) in a total reaction
volume of 50 µL. PCR products were electrophoresed on
1.2% agarose gel containing 0.1% ethidium bromide.
Positive and negative controls were run concurrently to
exclude DNA contamination.
Rat iNOS and eNOS conditions
After initial denaturation at 95°C for 2 min, 25–35 cycles
of amplifications at 94°C 30 sec, 60°C for 30 sec and
72°C for 45 sec were carried out using Perkin-Elmer 2400
thermal cycler.
Human iNOS and eNOS conditions
The thermocycle consisted of 94°C for 30 sec, 58°C
(eNOS)/60°C (i NOS and GAPDH) for 30 sec and 72°C
for 45 sec. The numbers of amplification cycles were 28–
35 (iNOS and eNOS) and 25 (GAPDH).
Quantitative Real Time-PCR analysis
Due to the difficulty of growing large numbers of mouse
AEC cells, quantitative real-time RT-PCR, which only
requires small amounts of RNA, was chosen to determine
mouse iNOS mRNA levels and β-actin (internal stand-
ard). Quantification of mRNA was performed by deter-
mining the threshold cycle (CT) on ABI PRISM 7700
Sequence Detector (Perkin-Elmer, Applied Biosystem).
Standard curves were constructed using the values
obtained from serially diluted positive control mouse
iNOS plasmid.
Real time-PCR was performed in 50 µl reaction volumes
containing 2X TaqMan Universal PCR Master Mix 25 µl
(Roche, Branchburg, New Jersey, USA), 2.5 µl 18 µM
sense/antisense primers, 2.5 µl 5 µM probe and 7 µl cDNA
samples (Table 1). The following thermal profile was
used: 2 min at 50°C, 10 min at 95°C and 50 cycles of
95°C for 15 sec, 60°C for 1 min.
iNOS/eNOS Western-Blot
CSS-treated RBL-2H3 and A549 cells were rinsed with PBS
and isolated by scraping in ice cold radio-immunoprecip-
itation (RIPA) buffer (1% NP-40, 0.5% sodium deoxycho-
late, 0.1% SDS in PBS) with freshly added aprotinin (30
µl/mL RIPA). Cell lysate was passed several times through
a 25 gauge needle to shear the DNA and incubated 30
minutes on ice. RIPA (10 µl/ml) with 10 mg/ml phenyl-
methylsulfonylfluoride (PMSF) was added and cell lysate
was microcentrifuged at 12,000 rpm for 20 minutes at
4°C. Protein concentration was determined using the
Bradford method (Bio-Rad, Hercules, CA, USA). Superna-
tants (20 µg) were loaded on NuPAGE™ 4–12%Bis-Tris
Gels (Invitrogen Corp.) and transferred to nitrocellulose
membranes. The membranes were blocked overnight in
5% skimmed milk and incubated for 1 h at room temper-
ature with primary antibodies at dilutions ofRespiratory Research 2005, 6:108 http://respiratory-research.com/content/6/1/108
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1:3000(iNOS/eNOS, BD Transduction Laboratories, San
Diego, CA, USA). Peroxidase-labeled secondary antibody
rabbit anti-mouse IgG was added at a dilution of 1:1000
(DAKO, CA, USA) for 1 h at RT. Membranes were devel-
oped with Enhanced Chemiluminescence Reagent (Per-
kin-Elmer Life Sciences, Boston, MA, USA) for 1 min and
exposed for 30 sec to scientific imaging film (BioMax,
Kodak, Rochester, USA).
Flow cytometric analyses of iNOS/eNOS proteins
CSS (1%) was added to RBL-2H3 and A549 cells for 24 h,
which were then trypsinized and fixed in 4% formalde-
hyde. Cells were permeabilized in 0.15% saponin PBS/2%
BSA for 1 h on ice and washed in PBS/2% BSA. Subse-
quently, cells were incubated in 10 µg/mL anti-iNOS or
20 µg/mL anti-eNOS (BD Transduction Laboratories) for
30 mins on ice, washed twice and added goat anti-mouse
IgG conjugated with FITC (DAKO) for further 30 mins in
the dark on ice. Cells were washed, resuspended in 500 µl
1% formaldehyde, and analyzed by flow cytometry (BD
FACSort). Mouse IgG1 and IgG2a (DAKO) were used as
negative controls for iNOS and eNOS antibodies,
respectively.
Cell viability and cytotoxicity
Viability and cytotoxicity were assessed by trypan blue
vital dye exclusion and lactate dehydrogenase release
(LDH Kit, Sigma).
Statistical analysis
Data are expressed as mean ± SEM. Analysis was per-
formed by one-way ANOVA with the application of Dun-
nett's multiple comparisons test, and a p value <0.05 was
considered significant. Data are representative of at least 3
different experiments. In the case of data expressed as per-
centage of baseline, the ANOVA and subsequent compar-
isons were performed on the raw data, prior to
transformation.
Results
Effect of CSS on degranulation and [NOX] generation by 
RBL-2H3
RBL-2H3 cells activated with either IgE/DNP or A23187
showed a concentration-dependent decrease in degranu-
lation after incubation with CSS (0.125%–1.0%) for 6 h
(Fig 1, p < 0.0001, ANOVA). Treatment with CSS
decreased the percentage of beta-hexosaminidase release
by up to 89% at 1.0% CSS. The CSS-induced inhibition of
beta-hexosaminidase was also observed after 2 h incuba-
tion (data not shown). As shown in Figure 1, RBL-2H3
treated with CSS (0.125% to 1.0%) for 24 h resulted in a
concentration-related inhibition of nitrite production (p
< 0.05, ANOVA, where baseline NOx = 3.04 +/- 0.21 µM),
with only a slight inhibition of nitrite at 6 h (p > 0.05, data
not shown). Viability of RBL-2H3 and epithelial cells
remained constant (generally >90%) before and after CSS
treatment.
Effect of nicotine on degranulation and [NOX] in RBL-
2H3, A549, NHTBE, and airway epithelial cells (AEC)
In order to investigate whether nicotine, the major com-
ponent of cigarette smoking in particulate phase, is
responsible for the inhibition of degranulation and pro-
duction of nitric oxide, RBL-2H3 cells were incubated in
nicotine solutions (62.5–250 µM) adjusted to physiolog-
ical pH for 24 h. Neither degranulation nor production of
nitric oxide was affected (Figure 2). Incubation of A549
cells with nicotine (31.25–400 ng/ml) for 48 h caused a
significant decrease in production of NOx, but incubation
of NHTBE and AEC cells with nicotine solutions (31.25
ng/ml–400 ng/ml) did not demonstrate any significant
change (Table 2).
Effects of NO pathway inhibitors on degranulation of RBL-
2H3
To investigate whether the NO present in CSS may have a
role in mast cell inhibition, a NO scavenger (hemoglobin)
was pre-incubated for 1 h with CSS. A NO donor (SNP)
was used as a positive control in studies without CSS. In
addition, in case CSS stimulated the production of NO in
these cells, an inhibitor of NOS (L-NMMA), and a cGMP
Table 1: PCR primers as used in Methods.
NOS isoform Primer sequence
Rat iNOS [26] sense:5'-GGACCACCTCTATCAGGAA-3', antisense 5'-CCTCATGATAACGTTTCTGGC-3';
Rat eNOS [27] sense: 5'-TACCAGCCGGGGGACCAC-3', antisense: 5'-CGAGCTGAC-AGAGTAGTA-3'.
Human iNOS [28] sense: 5'-GAGCTTCTACCT-CAAGCTATC-3', antisense: 5'-CCTGATGTTGCCATTGTTGGT-3';
Human eNOS sense:5'-GCACAGGAA-ATGTTCACC TAC-3', antisense: 5'-CACGATGGTGAC-TTTGGCTAG-3'.
Mouse iNOS (real time PCR) probe sense: 5'-CAGCTGGGCTGTACAAACCTT-3', antisense: 5'-CATTGGAAGTGAAGCGTTTCG-3', 5'-
6FAM (fluorescent reporter dye, 6-carboxyfluorescein)-CGGGCAGCCTGTGAGACCTTTGA-TAMRA 
(quenching agent, 6-carboxytetramethylrhodamine, Applied Biosystems, CA, USA).Respiratory Research 2005, 6:108 http://respiratory-research.com/content/6/1/108
Page 5 of 9
(page number not for citation purposes)
with CSS (0.25%–1.0%) resulted in a dose-related inhibi-
tion of NO production, which ranged between 47 and
67% inhbition with 1% CSS (baseline mean (SD) NOx of
the cell lines were: A549 2.7 +/- 0.16 µM; mouse AEC 1.34
+/- 0.2 µM, and NHTBE 1.56 +/- 0.18 µM, Figure 3).
Expression of NOS isoforms
Incubation of A549 cells with 1% CSS at different time-
points caused a time-dependent decrease in iNOS mRNA
levels (Figure 4). No iNOS mRNA was detected after 6 h
CSS incubation in this cell line. The same pattern was
observed in NHTBE which only expressed eNOS mRNA.
eNOS mRNA was not detected in A549 cells. In RBL-2H3
cells, the eNOS mRNA band decreased at 3 h, although it
returned to control levels after 24 h. Nicotine treated RBL-
2H3 cells resulted in a slight decrease in eNOS mRNA
expression. There was no iNOS mRNA observed in this
basophilic cell line.
Effects of CSS on the release of beta-hexosaminidase and  NOx production from RBL-2H3 Figure 1
Effects of CSS on the release of beta-hexosaminidase and 
NOx production from RBL-2H3. Cells were passively sensi-
tised with anti-DNP IgE, and incubated with 0.125–1% CSS 
for 6 hrs prior to activation with DNP. There is a CSS con-
centration-related decrease in the release of beta hexosami-
nidase. NOx formation was similarly decreased after 24 h 
incubation with the same range of CSS. Data are the means 
of 6 experiments with the mean and S.E.M. expressed as % of 
control, where baseline NOx = 3.04 +/- 0.21 µM, (ANOVA 
performed on raw data, *p < 0.001 with Dunnett's multiple 
comparison test compared to baseline values).
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Effects of nicotine on the release of beta-hexosaminidase and  NOx production from RBL-2H3 Figure 2
Effects of nicotine on the release of beta-hexosaminidase and 
NOx production from RBL-2H3. Cells were passively sensi-
tised with anti-DNP IgE, incubated in nicotine solutions 
(62.5–250 µM) for 24 h, and then activated with DNP for 
beta hexosaminidae release, or accumulated NOx measured. 
No significant effects were seen. Data are the means of 4 
experiments with the mean and S.E.M. expressed as % of 
control where mean (SD) baseline NOx = 3.5 +/- 0.11 µM 
(ANOVA performed on raw data, p > 0.05).
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Table 2: Effects of nicotine on the production of NO, measured as NOx from A549, AEC, and NHTBE cell lines over 48 hrs. Data are 
expressed as mean (S.E.M.) % of control of 3 experiments (ANOVA performed on raw data, * p < 0.05 in A549 group; p > 0.05 in AEC 
and NHTBE groups; Dunnett's multiple comparison test)
NOx (Percentage of Control)
Nicotine(µM) 31.25 62.5 125 250
A549 Cell Line 67.0 ± 5.79* 65.0 ± 7.87* 69.8 ± 7.12* 69.4 ± 7.81*
AEC Cells 112.8 ± 25.06 120.2 ± 9.70 105.7 ± 20.68 108.5 ± 22.95
NHTBE Cell Line 87.9 ± 8.61 83.4 ± 10.53 87.9 ± 3.37 99.9 ± 0.07Respiratory Research 2005, 6:108 http://respiratory-research.com/content/6/1/108
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Quantitative Real Time-PCR analysis
Using the technique of real-time PCR to detect changes in
AEC iNOS expression with 1% CSS, a progressive fall in
copy number was seen over 24 h (Figure 5). The time-
course is similar to that seen in the RT-PCR data for the
A549 cells above.
NOS protein expression by Western-Blot and flow 
cytometry
Using flow cytometry to detect iNOS positive cells, the
number of cells expressing iNOS protein were seen to be
decreased by 1% CSS in A549 cells. The ratio of positive to
negative cells declined from 1.60 to 1.29 (t = 8.931, p =
0.012, paired t test, two-tailed). Similarly, eNOS positive
RBL-2H3 cells were decreased after 1% CSS treatment
from 2.78 to 2.24 ± 0.17. iNOS and eNOS protein levels
were undetectable by immunoblot.
Effects of NAC on CSS-induced inhibition of degranulation 
of RBL-2H3
To investigate whether free radicals in CSS contribute to
the inhibition of degranulation, RBL-2H3 cells were incu-
bated with free radical scavenger N-acetyl-L-cysteine
(NAC, 1 mM) for 30 min prior to their incubation with
CSS. Compared with control CSS exposure and activation
there was a significant reversal of the CSS-induced inhibi-
tion (Figure 6).
Discussion
Nitric oxide is a ubiquitous intracellular and intercellular
signaling molecule, which plays a role in the functions of
various inflammatory cells including mast cells, lym-
phocytes, neutrophils and macrophages [30]. NO can
have deleterious or beneficial roles in inflammatory con-
ditions depending on the setting because of its role as
both an immune mediator and an effector molecule [30].
There is increasing evidence that the interaction between
NO and mast cells is important in the control of the
human nasal airway response, the physiological and path-
ological regulation in immune system, and the inhibition
of gastric acid secretion [30]. Some researchers have
reported that NO may modulate mast cell pre-formed
mediator release[31]. For instance, an increase in cGMP
levels was found to inhibit histamine release in rat perito-
neal mast cells which was reversed by L-NMMA (32).
Brooks et al. [32] demonstrated that NO induced by inter-
feron-gamma could inhibit the IgE-activated secretory
function of mouse mixed peritoneal mast cells. Koranteng
et al. [34] reported that NO generation inhibits pre-
formed mediator release in murine peritoneal mast cells,
but not in other mast cells which were of a different phe-
notype. CSS has variable effects upon isolated mast cells
[22], but in vivo has been clearly demonstrated to reduce
exhaled NO and the mechanism for this reduction was
therefore studied in in vitro models of airway epithelial
cells and mast cells.
The effects of cigarette smoke upon the NO pathways and
NOS isoenzymes are controversial and may vary accord-
ing to the disease, model or location of the NOS. For
example, while exhaled NO has been shown to be
decreased in humans after acute cigarette exposure, iNOS
mRNA expression increased in the lungs of rats exposed to
cigarette smoke, while nNOS showed a longer term
increase in both transcription and translation [3,5,35,36].
Cigarette smoke has been shown, however, to cause a
reduction in nitrite concentration and iNOS expression in
a murine lung epithelial cell line in vitro[37]. In contrast,
Comhair et al showed no change in iNOS expression in
airway cells from healthy subjects exposed to cigarette
smoke [38]. The effects of cigarette smoke on NOS in the
vasculature has shown a reduction in ecNOS in the pul-
monary vessels in vitro and in vivo [6,39], genetic
Effects of CSS on the production of NOx from A549, mouse  AEC, and NHTBE Figure 3
Effects of CSS on the production of NOx from A549, mouse 
AEC, and NHTBE. Cells were incubated with CSS for 24 h 
(AEC and NHTBE) or 48 h (A549). NOx production was 
assessed from the supernatants from each condition and cell 
line. Data are the means of 3 experiments with the mean and 
S.E.M. expressed as % of control. Baseline mean (SD) NOx of 
the cell lines were: A549 2.7 +/- 0.16 µM; mouse AEC 1.34 
+/- 0.2 µM, and NHTBE 1.56 +/- 0.18 µM. ANOVA was per-
formed on raw data: A549, *p < 0.05; AEC, *p < 0.05, 1% 
CSS compared with control; NHTBE, *p < 0.01, 1.0-0.5% 
CSS compared with control, *p < 0.05, 0.25% CSS vs. con-
trol; Dunnett's multiple comparison test.
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variation in man, [40,41] while vascular intimal
thickening and up – regulated iNOS has been described in
mice [42]. These seemingly contradictory effects are prob-
ably explained in part by the different tissue situations
and also by variation in the constituents of the cigarette
smoke. This is an important factor in the preparation of
the CSS and while CSS represents the aqueous phase of
the stimulus, the gaseous portion may easily contain addi-
tional stimuli which we did not study. For these reasons
investigators are often exposing cells in vitro to direct cig-
arette smoke rather than CSS alone to more accurately
simulate the in vivo situation.
The major findings of this study were that CSS inhibited
mast cell degranulation, production of NO by mast cells
and tracheobronchial epithelial cells, as well as expression
of the dominant NOS isoform by these cells. We had
hypothesised that the NOX-rich CSS might exert a negative
feedback mechanism upon NO release from these epithe-
lial and mast cells. The addition of scavengers did not
inhibit the effect, nor did SNP, a NO donor mimic CSS,
RT-PCR analysis of NOS expression Figure 4
RT-PCR analysis of NOS expression. Panel A. Time course of 
the effect of 1% CSS upon A549 iNOS mRNA expression. 
Upper panel: Lane 1: control, Lane 2: 3 h, Lane 3: 6 h, Lane 4: 
24 h, Lane 5: 24 h CSS exposure and then cells returned to 
normal media for further 24 h; bottom panel: GAPDH corre-
sponding to each sample. PCR gels shown are representative 
of three separate experiments. There was a decrease in 
iNOS mRNA in A549 cells reaching undetectable levels at 6 
h, which persisted to 24 hr, even after further incubation in 
normal culture media. Panel B. Time course of the effect of 
1% CSS on NHTBE eNOS mRNA expression. Upper panel: 
Lane 1: control, Lane 2: 3 h, Lane 3: 6 h, Lane 4: 24 h, Lane 5: 
24 h CSS and returned to normal media for further 24 h; 
bottom panel: GAPDH corresponding to each sample. PCR 
gels are representative of three separate experiments. Simi-
lar changes were seen in the mRNA expression of eNOS in 
the NHTBE line as in the A549 cells with decreased levels at 
3 h which persisted throughout the study period. Panel C. 
Effect of 1% CSS and 100 µM nicotine on rat RBL-2H3 eNOS 
mRNA expression. Upper panel: Lane 1: control, Lane 2–4: 
CSS 3 h, 6 h, 24 h, Lanes 5–7: nicotine 3 h, 6 h, 24 h; bottom 
panel: GAPDH corresponding to each sample. PCR gels are 
representative of three separate experiments. After CSS, 
there was a decline in mRNA at 3 h which returned to base-
line by 24 h, while exposure to nicotine showed a decrease 
at 6 and 24 h.
Panel A Panel B
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rat RBL-2H3 eNOS
rat RBL-2H3 GAPDH
Effects of CSS on iNOS mRNA from mouse AEC by real- time PCR Figure 5
Effects of CSS on iNOS mRNA from mouse AEC by real-
time PCR. Quantitative real-time RT-PCR was performed to 
determine mouse iNOS mRNA levels. Quantification of 
mRNA was performed by determining the threshold cycle 
and standard curves were constructed using the values 
obtained from serially diluted positive control mouse iNOS 
plasmid, and determining the values for experimental samples 
from these curves. A progressive fall in copy number was 
seen in AEC iNOS expression with 1% CSS, over 24 h. Data 
points represent 3 replicates with S.E.M.
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thus disproving this hypothesis. In addition, NOS
inhibitors did not affect the response, indicating that the
endogenous cellular production of NO was not involved
in the response to CSS. Nicotine appeared reduce the abil-
ity of the A549 cell line to generate NOx, but this was not
dose-dependent and was not seen in other cell lines. The
significance of this apparently idiosyncratic response is
unclear.
The effects of CSS shown here could not be attributed to
the pharmacological activity of nicotine, but may to be
related to oxidative free radicals as they are inhibited by
N-acetyl-L-cysteine [44]. NAC, an anti-oxidant, has been
studied quite extensively for its ability to exert protective
effects. Because of its SH group, NAC scavenges H2O2
(hydrogen peroxide), •OH (hydroxyl radical), and HOCl
(hypochlorous acid). In addition, NAC reduces cellular
production of pro-inflammatory mediators [43]. CSS
causes a reduction in NOS expression, and the mecha-
nism would therefore seem to be at the level of the gene.
The inhibition of the effects of CSS by NAC would appear
to be congruent with the observations that NAC can
reduce DNA adducts, clastogenic changes and other cellu-
lar toxic effects caused by mutagens and cigarette smoke in
in vitro and in animal models, reviewed in De Vries 1993
[43]. These observations have led to the use of NAC in
clinical trials in an attempt prevent or reduce the risk of
recurrence of cancers by using NAC and other anti-oxi-
dants [44]. This study did not use additional methods to
confirm that the effect of CSS was via reactive oxygen spe-
cies and NAC has complex attributes with actions other
than by acting purely as an anti-oxidant, e.g. mucolytic
activity, L-cysteine donation, and these could also play a
role in modulating the effects of cigarette smoke [44].
Abbreviations
airway epithelial cells, AEC; cigarette smoke solution,
CSS; endothelial nitric oxide synthase, eNOS; inducible
nitric oxide synthase, iNOS; N-acetyl-L-cysteine, NAC;
normal human tracheal bronchial epithelial cells,
NHTBE; nitric oxide, NO; polymerase chain reaction,
PCR.
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